Faculty of Medicine, The Chinese University of Hong Kong. Our commitment to innovation, creativity, ethics, compassion and professional development sets us apart from the rest.
Graduate Entry Track (GET)
A four-year medicine programme
for degree holders and graduating students
Recruitment of
50 Principal Investigators
A Personalised Curriculum Designed by You
News & Events
News20 June 2025
CUHK study finds clues why aspirin fails to prevent preeclampsia in some high-risk pregnancies
Explore More
News5 June 2025
CUHK reveals lifestyle intervention can alleviate metabolic dysfunction-associated steatotic liver disease in nearly 70% of people living with HIV
News29 May 2025
CUHK study shows 1 in 1,000 Hong Kong people will have inflammatory bowel disease in the next decade Annual healthcare costs will exceed HK$400 million by 2034
Explore More
CU Medicine and the Department of Health co-organised the first ever “Hong Kong International Medical Device Regulatory Forum”
28 May 2025
Our Schools
Most Read
29 November 2023
CUHK announces survey results on the mental health of local child, adolescent and elderly populations
EXPLORE MORE
MBChB & GPS
EXPLORE MORE
19 November 2024
CU Medicine receives the Li Ka Shing Foundation’s donation of Asia’s first Histotripsy 2.0 system 30 patients sponsored to receive novel treatment for liver tumours
EXPLORE MORE
19 October 2023
CU Medicine discovers gut microbiome and metabolome markers that predict long-term COVID-19 vaccine effectiveness
EXPLORE MORE
Summer Clinical Attachment Programme 2025
EXPLORE MORE
7 August 2024
CU Medicine’s admission score tops medical schools in Hong Kong; Around half of the top 100 DSE students choose CU Medicine, including five top scorers and “super” top scorers; 72% of the total intake goes to DSE students
EXPLORE MORE
Summer Clinical Attachment Programme 2024
EXPLORE MORE
7 May 2019
CUHK Study First Proves Low-Concentration Atropine Eye Drops Reduce Myopia Progression in Children with Minimal Side Effects
EXPLORE MORE
19 May 2025
CUHK-led multinational study shows new China-developed cancer drug D3S-001 is effective in treating solid tumours, including lung, colorectal and pancreatic cancer
EXPLORE MOREFollow Us
